Table 2.
Viability rates measured by the xCELLigence RTCA method after 24 hours of treatment of MCF-7 cells with different PTX concentrations.
| PTX Concentration (µM) | Viability (%) |
|---|---|
| Control (0 µM) | 100 |
| 5 µM | 46.64 ± 0.42** |
| 10 µM | 61.62 ± 0.49** |
| 15 µM | 37.25 ± 0.48** |
| 20 µM | 38.33 ± 0.13** |
| 25 µM | 31.78 ± 1.82** |
| 50 µM | 41.02 ± 0.12** |
| 80 µM | 37.65 ± 0.17** |
Note: **p < 0.01 when compared with the control.